The SHARE study is an international multidisciplinary longitudinal survey. The panel survey has been conducted approximately every other year for over 20 years. In an analysis published in 2025, data from the ninth wave of the survey was analyzed to find out more about the prevalence of polypharmacy in different countries and to break down which factors are associated with it.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- A syndrome between decompensation and chronification
Worsening Heart Failure
- Actinic keratosis
Field-directed therapy methods: what the European guideline recommends
Opicapon: double benefit for motor function and sleep in Parkinson’s disease
- Colorectal cancer
Is exercise better than medication?
- Itching in primary biliary cholangitis
When the skin becomes agony
- TREATswitzerland Register
Evaluation of system therapies for AD
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses